TECXTectonic Therapeutic, Inc.

Healthcare
$22.68+52% 1Y

The financials

Tectonic Therapeutic, Inc. by the numbers

The next results filing is expected around Nov 5, 2026, the same week as a year ago.

Tectonic Therapeutic, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$24M−$22Mn/a
Net income−$22M−$20Mn/a
Diluted EPS−$1.18−$1.07n/a

Biotechnology

Ranks #33 of 196 by RyuScore

Compare peers
DMAC+0.38%
DiaMedica Therapeutics Inc.
EDIT+3.3%
Editas Medicine, Inc.
OVID-0.64%
Ovid Therapeutics Inc.
NGNE+2.3%
Neurogene Inc.
RGNX+6.5%
REGENXBIO Inc.
AVIR+2.6%
Atea Pharmaceuticals, Inc.